Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2012
06/13/2012CN102488835A Preparation process for chlorogenic acid ecological preparation originating from Arctium lappa Linne leaves
06/13/2012CN102488830A Pharmaceutical composition for lowering blood sugar
06/13/2012CN102488827A Preparation method for Yuye decoction lyophilized orally administrated preparation
06/13/2012CN102488816A Chinese patent drug for insufficiency of kidney-yang
06/13/2012CN102488815A Buccal tablet for reducing blood sugar
06/13/2012CN102488810A Applications of huoxiangzhengqi soft capsule serving as medicinal preparations for treating cardiovascular and cerebrovascular diseases
06/13/2012CN102488773A Multifunctional health product
06/13/2012CN102488772A Chinese herbal composition for preventing or treating hyperlipemia
06/13/2012CN102488769A Diet pill
06/13/2012CN102488761A Traditional Chinese medicine composition for treating diabetes, preparation thereof and its preparation method
06/13/2012CN102488741A Preparation method of pueraria root flavone extract and its product
06/13/2012CN102488714A Gallnut aphid oil composition, preparation method and application of gallnut aphid oil composition
06/13/2012CN102488685A Application method of liposome preparation containing compound amino acid component
06/13/2012CN102488673A Probucol nanometer dispersion and preparation method thereof
06/13/2012CN102488669A Method for improving hygroscopicity of D-ribose
06/13/2012CN102488667A Glimepiride tablet and preparation method thereof
06/13/2012CN102488664A Pharmaceutical composition containing 12 vitamins
06/13/2012CN102488619A Device for continuously producing exenatide microspheres and method for controlling release rate of microspheres
06/13/2012CN102488281A Novel pure plant composite concentrated drinking liquid with blood sugar reducing effect, and preparation method thereof
06/13/2012CN102488251A Sea cucumber gelatin, preparation method thereof, medicine or health product containing sea cucumber gelatin, and application of sea cucumber gelatin
06/13/2012CN102488202A Medicinal composition for treating diabetes and preparation method thereof
06/13/2012CN102068475B Application and blood-sugar lowering effective part of trapa acornis nakano shell as well as extraction method of blood-sugar lowering effective part
06/13/2012CN102000264B Detection method of composition for treating climacteric syndrome
06/13/2012CN101970639B Microorganism producing cyclic compound
06/13/2012CN101947232B Use of cactus pear fruit polysaccharides in preparation of medicaments or health-care products
06/13/2012CN101869546B Supermolecular gel used for protecting photostability of vitamin A derivatives and its preparation method
06/13/2012CN101785813B Chinese herba preparation for regulating lipid and reducing weight
06/13/2012CN101658537B Hypoglycemic ferment compound and its preparation method
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101612184B Multiradiate fleabane extract, composition containing same, preparation method and application thereof
06/13/2012CN101444618B Pharmaceutical preparation containing exenatide
06/13/2012CN101386617B Substituted tetrahydroisoquinoline derivatives, preparation method thereof and pharmaceutical compositions containing same
06/13/2012CN101357141B Water-soluble mixing active pearl calcium and preparation method thereof
06/13/2012CN101352432B Technique of preparing nano vitamin E emulsion
06/13/2012CN101317650B Edible mushroom foods and preparing method thereof
06/13/2012CN101307085B SiRNA and recombination lentivirus from preventing hepcidin from regulating protein and uses thereof
06/13/2012CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/12/2012US8198330 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8197855 Compositions and methods for nutrition supplementation
06/12/2012US8197850 increase in the time corresponding to the plasma concentration maximum, without a very significant decrease in the bioavailability; comprises several thousand anti-hyperglycaemic (metformin) microcapsules; drug core with coating film
06/12/2012US8197848 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/07/2012WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
06/07/2012WO2012075342A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012WO2012075115A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012WO2012075081A2 High-strength testosterone undecanoate compositions
06/07/2012WO2012075026A1 Methods of treating obesity using an effective dose of a metap-2 inhibitor
06/07/2012WO2012075020A1 Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
06/07/2012WO2012074968A1 Methods of reducing risk of hepatobiliary dysfunction during rapid weight loss with metap-2 inhibitors
06/07/2012WO2012074184A1 Pharmaceutical composition for preventing or treating obesity comprising sphingosine-1-phosphate or a pharmaceutically acceptable salt thereof as an active ingredient
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012073965A1 Insulin secretagogue
06/07/2012WO2012073593A1 Manufacturing method for dried earthworm powder
06/07/2012WO2012073256A1 Salts of rosuvastatin
06/07/2012WO2012072691A1 Indanyloxydihydrobenzofuranylacetic acids
06/07/2012WO2012072082A1 Methods for increasing intracellular activity of hsp70
06/07/2012WO2012071706A1 Pharmaceutical composition for preventing and treating diabetes and its complications
06/07/2012WO2012033353A9 Sesterterpene compounds and use thereof
06/07/2012WO2011132075A3 A hydrate of a cyclohexanamine derivative
06/07/2012US20120142781 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States
06/07/2012US20120142778 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
06/07/2012US20120142774 Emulsifying preparation
06/07/2012US20120142766 Substituted 1,3-dioxanes and their uses
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142728 Chemical compound and its use
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142714 Bicyclic compound
06/07/2012US20120142712 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
06/07/2012US20120142709 Substituted pyridinone-pyridinyl compounds
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142706 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
06/07/2012US20120142705 Isatin and oxindole compounds
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142693 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142685 Organic compounds
06/07/2012US20120142674 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142657 Gaba-steroid antagonists and their use for the treatment of cns disorders
06/07/2012US20120142645 Neuroactive steroid compositions and methods of use for lowering cholesterol
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142636 Novel glucokinase activators and methods of using same
06/07/2012US20120142618 Ketogenic saccharides
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142612 Cytokine protein family
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120142588 Hsp therapy in conjunction with a low antigenicity diet
06/07/2012US20120142587 Liquid enteral nutritional composition with a low monovalent metal ion content
06/07/2012US20120142586 Treatment for obesity
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142582 Combination of Dopamine Agonists Plus First Phase Secretagogues for the Treatment of Metabolic Disorders
06/07/2012US20120141590 Technology for the Preparation of Microparticles
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 1298